Nuvectis Pharma, Inc. (NVCT) Dividend History

Company News

• Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

  Nuvectis Pharma, a clinical-stage biopharmaceutical company, announced the pricing of its $13.5 million public offering of 2.7 million shares of common stock at $5 per share. The company plans to use the proceeds to advance the development of its drug candidates NXP800 and NXP900.

  GlobeNewswire Inc.
• Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?

  The average of price targets set by Wall Street analysts indicates a potential upside of 229.3% in Nuvectis Pharma (NVCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

  Zacks Investment Research
• Insiders Buying Texas Capital Bancshares And 3 Other Stocks

  Although U.S. stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Nuvectis Pharma The Trade: Nuvectis Pharma, Inc. (NASDAQ: NVCT) 10% owner Charles Mosseri-Marlio acquired a total of 10,000 shares an average price of $13.97. To acquire these shares, it cost around $139,700. What’s Happening: Nuvectis Pharma recently announced FDA clearance of NXP900 IND. What Nuvectis Pharma Does: Nuvectis Pharma Inc is a ...

  Benzinga

  Featured Companies: IBCP RILY TCBI
• 10 Best Performing IPOs In Q1 2022

  Investing.com

  Featured Companies: CEG CRDO SQFT
• Stocks To Watch: Spotlight On Ukraine, FOMC Speakers, Target, Lucid And DraftKings

  Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

  Seeking Alpha

  Featured Companies: ACLX ADT COST CPNG DE DKNG DLTR DOOO EGAN FFIV GD GILT GT HPQ LCID MRVL MXL NTR QCOM ROST SAIL TGT WDAY